Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

The Pharmaceutical Journal

Editorial

More needs to be done to incentivise research into new indications for existing medicines

Don't overlook opportunities to repurpose existing drugsSubscription

More needs to be done to incentivise research into new indications for existing medicines.

Feature

Scientists are using systematic approaches to identify non-oncology drugs that can be used to treat cancer, but access to drugs and commercial challenges are hindering progress

Repositioning existing drugs for cancer treatmentSubscription

By

Scientists are using systematic approaches to identify non-oncology drugs that can be used to treat cancer, but access to drugs and commercial challenges are hindering progress.

Comment

Local NHS health bodies around the UK should follow Liverpool Clinical Commissioning Group’s decision to review spending on homeopathy, a treatment that lacks any reasonable supporting evidence of effectiveness

Stop funding treatments with insufficient evidence of efficacySubscription

By ,

Local NHS health bodies around the UK should follow Liverpool Clinical Commissioning Group’s decision to review spending on homeopathy, a treatment that lacks any reasonable supporting evidence of effectiveness.

Learning article

Warts and verrucas are common viral skin infections, affecting around 7–12% of the population at any one time, and are more common in children. They are caused by the human papilloma virus (HPV). In the image, micrograph of a common wart

Warts and verrucas: assessment and treatmentSubscription

By ,

Lesions caused by human papilloma virus often do not require treatment, but need to be assessed to rule out more serious conditions.

Careers

Being part of a buying group or franchise can help pharmacies benefit from increased buying power, improved marketing and administration support. In the UK, only Lloydspharmacy offers a full franchise scheme

Pharmacy franchises and buying groups: advantages and drawbacksSubscription

By

The first franchise of a multiple in the UK, Lloydspharmacy, recently opened in Gloucester. But what are the advantages of joining a franchise or buying group — and do they differ from one another?

News

People who take proton pump inhibitors (PPIs), commonly used drugs for heartburn, have a greater risk of suffering a heart attack whether or not they have any history of cardiovascular disease, suggests a data-mining study

Proton pump inhibitors are associated with increased risk of heart attack

Data mining research shows common heartburn drugs are linked to cardiovascular events.

A single injection of a patient’s own modified dendritic cells (pictured) appears to safely deliver anti-inflammatory and immunoregulatory effects for rheumatoid arthritis (RA), a phase I study has shown.

Injection of modified cells reduces inflammation in arthritis sufferersSubscription

A single injection of a patient’s own modified dendritic cells appears to be safe and to have anti-inflammatory and immunoregulatory effects in rheumatoid arthritis.

The Pharmaceutical Journal

20 June 2015, Vol 294, No 7867

Cover Story:

Scientists are using systematic approaches to identify non-oncology drugs that can be used to treat cancer, but access to drugs and commercial challenges are hindering progress.

Read more…

The Pharmaceutical Journal

View previous issue

YOUR RPS

English Pharmacy Board member Claire Anderson (pictured), professor of social pharmacy at the University of Nottingham, talks about the growing gap of UK universities' pass rates for the GPhC registration exam and the wider profession

Q&A: ‘We should be worried when students are failing to become pharmacists’Subscription

By

As wide variation persists between UK universities’ pass rates for the GPhC registration exam, Stephen Robinson asks English Pharmacy Board member Claire Anderson, professor of social pharmacy at the University of Nottingham, what this means for students and the wider profession.

Notice-board

For latest notifications, opportunities and product updates, visit the notice-board page here.

Announcements

For official announcements from The Royal Pharmaceutical society please visit the announcements page here.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.